Estrogen Affects Thymosin Beta 4 Levels But Not Thymosin Alpha 1 in Women

Thymosin beta 4 blood levels varied with estrogen status in women — highest in those on birth control — while thymosin alpha 1 stayed constant regardless of hormonal state.

Suh, B Y et al.·American journal of obstetrics and gynecology·1985·Preliminary EvidenceCross-Sectional
RPEP-00032Cross SectionalPreliminary Evidence1985RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Normal thymosin alpha 1 levels were similar across all groups of women tested, regardless of their hormonal status. This peptide appears unaffected by estrogen.

Thymosin beta 4 told a different story. Castrated women not receiving estrogen had reduced levels. Postmenopausal women on chronic estrogen therapy had even lower thymosin beta 4. Castrated women on estrogen also showed decreased levels.

Normal women in the early follicular phase (low estrogen point of the menstrual cycle), women with premature ovarian failure, and postmenopausal women not on estrogen all had similar thymosin beta 4 levels. But the premature ovarian failure and postmenopausal groups showed wide variation, suggesting these are not uniform populations.

Key Numbers

How They Did This

Cross-sectional study of 87 women. Blood samples were taken in the morning. Thymosin alpha 1 and beta 4 were measured by radioimmunoassay in the same samples. Women were grouped by hormonal status: normal cycling, premature ovarian failure, postmenopausal (with and without estrogen), castrated (with and without estrogen), and gonadal dysgenesis.

Why This Research Matters

This showed that sex hormones specifically regulate certain thymic peptides. Since thymosin beta 4 is involved in immune regulation, wound healing, and inflammation, estrogen's ability to lower its levels could partly explain sex differences in immune function and autoimmune disease rates.

The Bigger Picture

The link between estrogen and thymosin beta 4 may help explain sex differences in immune function and wound healing, since beta 4 is involved in tissue repair and immune regulation.

What This Study Doesn't Tell Us

This was an observational cross-sectional study. It cannot prove estrogen causes the thymosin beta 4 decrease, only that the two are linked. The sample groups were small, and the wide variability in some groups makes conclusions uncertain. The mechanism by which estrogen affects thymosin beta 4 was not explored.

Questions This Raises

  • ?Does elevated thymosin beta 4 during contraceptive use affect wound healing or immune function?
  • ?Is the estrogen-beta 4 connection direct or mediated by the thymus?
  • ?Do postmenopausal women on HRT show similar beta 4 changes?

Trust & Context

Key Stat:
Beta 4 elevated with estrogen While alpha 1 remained constant across all hormonal states
Evidence Grade:
Preliminary cross-sectional study — shows correlation but cannot prove causation.
Study Age:
Published in 1985 — early observation of hormone-peptide interactions.
Original Title:
Modulation of thymosin beta 4 by estrogen.
Published In:
American journal of obstetrics and gynecology, 151(4), 544-9 (1985)
Database ID:
RPEP-00032

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

What does thymosin beta 4 do?

Thymosin beta 4 is a peptide involved in wound healing, tissue repair, and immune cell development. It promotes cell migration and reduces inflammation.

Why would estrogen affect an immune peptide?

Estrogen receptors exist on immune cells and thymus tissue. Estrogen can modulate gene expression in these cells, potentially increasing thymosin beta 4 production.

Read More on RethinkPeptides

Cite This Study

RPEP-00032·https://rethinkpeptides.com/research/RPEP-00032

APA

Suh, B Y; Naylor, P H; Goldstein, A L; Rebar, R W. (1985). Modulation of thymosin beta 4 by estrogen.. American journal of obstetrics and gynecology, 151(4), 544-9.

MLA

Suh, B Y, et al. "Modulation of thymosin beta 4 by estrogen.." American journal of obstetrics and gynecology, 1985.

RethinkPeptides

RethinkPeptides Research Database. "Modulation of thymosin beta 4 by estrogen." RPEP-00032. Retrieved from https://rethinkpeptides.com/research/suh-1985-modulation-of-thymosin-beta

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.